Get started
Author

Wajma Shahbaz

Pre-Apheresis Prediction of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma
2024 · Kai Rejeski, Doris K. Hansen, et al. · Blood · 8
Beyond ECOG: Assessment of physical function enhances risk stratification prior to CAR-T cell therapy
2025 · Alessandra Holzem, Michael Ingrisch, et al. · Blood · 1
PDF
Gender Disparities in Health-related Quality of Life Outcomes Following Radical Cystectomy for Bladder Cancer
2025 · Thilo Westhofen, Lennert Eismann, et al. · European Urology Focus · 1
Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers
2025 · Peter May, Michael Rassner, et al. · Haematologica · 1
PDF
Early and sex-specific dynamic changes of the modified Glasgow Prognostic Score correlate with survival and immunotoxicities in patients undergoing allogeneic hematopoietic stem cell transplantation
2026 · Hannah Thurisch, Kathrin C. Althoff, et al. · Frontiers in Immunology
(Über-)Leben mit Krebs: Sekundärmalignome (inkl. Genetik)
2025 · Wajma Shahbaz, Philipp A. Greif · TumorDiagnostik & Therapie
(Über-)Leben mit Krebs: Sekundärmalignome (inkl. Genetik)
2024 · Wajma Shahbaz, Philipp A. Greif · DMW - Deutsche Medizinische Wochenschrift
D DX41-Low Expression Mimics Germline DDX41-Phenotype in Acute Myeloid Leukemia
2023 · Wajma Shahbaz, Vindi Jurinovic, et al. · Blood
PDF
Works count: 8
Citation count: 11
H-index: 1
I10-index:
Year
Topic
Type